Labgenomics Co (084650.KQ) Stock Price
Labgenomics Co Price
Revenue has compounded at 14.6% per year over the past 13 years to 88.16 B KRW. Earnings per share have grown at 44.2% per year over the last 10 years. Labgenomics Co's net margin stands at -73.0%, down from 41.4% several years earlier. Labgenomics Co currently offers a dividend yield of about 13.90%. The payout ratio is around 3% of earnings. Analysts set a median price target of 5,100.00 KRW, implying 183.6% above the current price. Of 5 analysts, 4 rate the stock a buy — an overall Buy consensus.
Labgenomics Co stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Labgenomics Co business model & stock analysis
Frequently asked questions about Labgenomics Co
Analysts currently set an average price target of 5,100.00 KRW for the Labgenomics Co stock (median: 5,100.00 KRW), implying +183.6 % versus the latest price. The consensus is based on 5 analyst ratings.
5 analysts currently rate the Labgenomics Co stock: 4 recommend buying, 1 holding and 0 selling.
Converted at the current exchange rate, the Labgenomics Co share trades at 1.19 EUR (1,798.00 KRW).
The revenue cannot currently be calculated for Labgenomics Co.
The expected profit of Labgenomics Co is 35.39 B KRW. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Labgenomics Co is currently 0.46. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Labgenomics Co stock.
The P/S cannot be calculated for Labgenomics Co currently.
The Eulerpool Quality Score for Labgenomics Co is 1/10.
The ISIN of Labgenomics Co is KR7084650001. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Labgenomics Co is 084650.KQ. The ticker symbol is used to trade Labgenomics Co shares on the stock exchange.
Labgenomics Co stock
Labgenomics Co Peer Group
Labgenomics Co FIGI
All fundamentals and in-depth analysis of Labgenomics Co
Our stock analysis for Labgenomics Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Labgenomics Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.